China High Throughput Screening (HTS) Market Report & Forecast 2021-2027

Publisher Name :
Date: 12-Nov-2021
No. of pages: 92
Inquire Before Buying

China High Throughput Screening (HTS) Market, By Type, 2016-2021, 2022-2027 ($ Millions)

China High Throughput Screening (HTS) Market Segment Percentages, By Type, 2020 (%)

- Cell-based Assays

- 3D - Cell Cultures

- Ultra High Throughput Screening

China High Throughput Screening (HTS) Market, By Application, 2016-2021, 2022-2027 ($ Millions)

China High Throughput Screening (HTS) Market Segment Percentages, By Application, 2020 (%)

- Drug Discovery Programs

- Chemical Biology Programs

- Biochemical Screening

- Cell- & Organ-based Screening

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies High Throughput Screening (HTS) revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies High Throughput Screening (HTS) revenues share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Agilent Technologies, Inc.

- Danaher Corporation

- Thermofisher Scientific, Inc.

- PerkinElmer, Inc.

- Tecan Group Ltd.

- Merck Millipore

- Bio-Rad Laboratories

- Hamilton Company

- Axxam S.p.A.

- Aurora Biomed

China High Throughput Screening (HTS) Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 High Throughput Screening (HTS) Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China High Throughput Screening (HTS) Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China High Throughput Screening (HTS) Overall Market Size
2.1 China High Throughput Screening (HTS) Market Size: 2021 VS 2027
2.2 China High Throughput Screening (HTS) Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top High Throughput Screening (HTS) Players in China Market
3.2 Top China High Throughput Screening (HTS) Companies Ranked by Revenue
3.3 China High Throughput Screening (HTS) Revenue by Companies
3.4 Top 3 and Top 5 High Throughput Screening (HTS) Companies in China Market, by Revenue in 2020
3.5 Companies High Throughput Screening (HTS) Product Type
3.6 Tier 1, Tier 2 and Tier 3 High Throughput Screening (HTS) Players in China Market
3.6.1 List of Tier 1 High Throughput Screening (HTS) Companies in China
3.6.2 List of Tier 2 and Tier 3 High Throughput Screening (HTS) Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China High Throughput Screening (HTS) Market Size Markets, 2021 & 2027
4.1.2 Cell-based Assays
4.1.3 3D - Cell Cultures
4.1.4 Ultra High Throughput Screening
4.2 By Type - China High Throughput Screening (HTS) Revenue & Forecasts
4.2.1 By Type - China High Throughput Screening (HTS) Revenue, 2016-2021
4.2.2 By Type - China High Throughput Screening (HTS) Revenue, 2022-2027
4.2.3 By Type - China High Throughput Screening (HTS) Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China High Throughput Screening (HTS) Market Size, 2021 & 2027
5.1.2 Drug Discovery Programs
5.1.3 Chemical Biology Programs
5.1.4 Biochemical Screening
5.1.5 Cell- & Organ-based Screening
5.2 By Application - China High Throughput Screening (HTS) Revenue & Forecasts
5.2.1 By Application - China High Throughput Screening (HTS) Revenue, 2016-2021
5.2.2 By Application - China High Throughput Screening (HTS) Revenue, 2022-2027
5.2.3 By Application - China High Throughput Screening (HTS) Revenue Market Share, 2016-2027
6 High Throughput Screening (HTS) Companies Profiles
6.1 Agilent Technologies, Inc.
6.1.1 Agilent Technologies, Inc. Company Details
6.1.2 Agilent Technologies, Inc. Business Overview
6.1.3 Agilent Technologies, Inc. High Throughput Screening (HTS) Introduction
6.1.4 Agilent Technologies, Inc. High Throughput Screening (HTS) Revenue in China Market (2016-2021)
6.1.5 Agilent Technologies, Inc. Recent Developments
6.2 Danaher Corporation
6.2.1 Danaher Corporation Company Details
6.2.2 Danaher Corporation Business Overview
6.2.3 Danaher Corporation High Throughput Screening (HTS) Introduction
6.2.4 Danaher Corporation High Throughput Screening (HTS) Revenue in China Market (2016-2021)
6.2.5 Danaher Corporation Recent Developments
6.3 Thermofisher Scientific, Inc.
6.3.1 Thermofisher Scientific, Inc. Company Details
6.3.2 Thermofisher Scientific, Inc. Business Overview
6.3.3 Thermofisher Scientific, Inc. High Throughput Screening (HTS) Introduction
6.3.4 Thermofisher Scientific, Inc. High Throughput Screening (HTS) Revenue in China Market (2016-2021)
6.3.5 Thermofisher Scientific, Inc. Recent Developments
6.4 PerkinElmer, Inc.
6.4.1 PerkinElmer, Inc. Company Details
6.4.2 PerkinElmer, Inc. Business Overview
6.4.3 PerkinElmer, Inc. High Throughput Screening (HTS) Introduction
6.4.4 PerkinElmer, Inc. High Throughput Screening (HTS) Revenue in China Market (2016-2021)
6.4.5 PerkinElmer, Inc. Recent Developments
6.5 Tecan Group Ltd.
6.5.1 Tecan Group Ltd. Company Details
6.5.2 Tecan Group Ltd. Business Overview
6.5.3 Tecan Group Ltd. High Throughput Screening (HTS) Introduction
6.5.4 Tecan Group Ltd. High Throughput Screening (HTS) Revenue in China Market (2016-2021)
6.5.5 Tecan Group Ltd. Recent Developments
6.6 Merck Millipore
6.6.1 Merck Millipore Company Details
6.6.2 Merck Millipore Business Overview
6.6.3 Merck Millipore High Throughput Screening (HTS) Introduction
6.6.4 Merck Millipore High Throughput Screening (HTS) Revenue in China Market (2016-2021)
6.6.5 Merck Millipore Recent Developments
6.7 Bio-Rad Laboratories
6.7.1 Bio-Rad Laboratories Company Details
6.7.2 Bio-Rad Laboratories Business Overview
6.7.3 Bio-Rad Laboratories High Throughput Screening (HTS) Introduction
6.7.4 Bio-Rad Laboratories High Throughput Screening (HTS) Revenue in China Market (2016-2021)
6.7.5 Bio-Rad Laboratories Recent Developments
6.8 Hamilton Company
6.8.1 Hamilton Company Company Details
6.8.2 Hamilton Company Business Overview
6.8.3 Hamilton Company High Throughput Screening (HTS) Introduction
6.8.4 Hamilton Company High Throughput Screening (HTS) Revenue in China Market (2016-2021)
6.8.5 Hamilton Company Recent Developments
6.9 Axxam S.p.A.
6.9.1 Axxam S.p.A. Company Details
6.9.2 Axxam S.p.A. Business Overview
6.9.3 Axxam S.p.A. High Throughput Screening (HTS) Introduction
6.9.4 Axxam S.p.A. High Throughput Screening (HTS) Revenue in China Market (2016-2021)
6.9.5 Axxam S.p.A. Recent Developments
6.10 Aurora Biomed
6.10.1 Aurora Biomed Company Details
6.10.2 Aurora Biomed Business Overview
6.10.3 Aurora Biomed High Throughput Screening (HTS) Introduction
6.10.4 Aurora Biomed High Throughput Screening (HTS) Revenue in China Market (2016-2021)
6.10.5 Aurora Biomed Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. High Throughput Screening (HTS) Market Opportunities & Trends in China Market
Table 2. High Throughput Screening (HTS) Market Drivers in China Market
Table 3. High Throughput Screening (HTS) Market Restraints in China Market
Table 4. Key Players of High Throughput Screening (HTS) in China Market
Table 5. Top High Throughput Screening (HTS) Players in China Market, Ranking by Revenue (2019)
Table 6. China High Throughput Screening (HTS) Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China High Throughput Screening (HTS) Revenue Share by Companies, 2016-2021
Table 8. Companies High Throughput Screening (HTS) Product Type
Table 9. List of Tier 1 High Throughput Screening (HTS) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 High Throughput Screening (HTS) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China High Throughput Screening (HTS) Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China High Throughput Screening (HTS) Revenue (US$, Mn), 2016-2021
Table 13. By Type - China High Throughput Screening (HTS) Revenue (US$, Mn), 2022-2027
Table 14. By Application - China High Throughput Screening (HTS) Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China High Throughput Screening (HTS) Revenue (US$, Mn), 2016-2021
Table 16. By Application - China High Throughput Screening (HTS) Revenue (US$, Mn), 2022-2027
Table 17. Agilent Technologies, Inc. Company Details
Table 18. Agilent Technologies, Inc. Business Overview
Table 19. Agilent Technologies, Inc. High Throughput Screening (HTS) Product
Table 20. Agilent Technologies, Inc. High Throughput Screening (HTS) Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Agilent Technologies, Inc. Recent Developments
Table 22. Danaher Corporation Company Details
Table 23. Danaher Corporation Business Overview
Table 24. Danaher Corporation High Throughput Screening (HTS) Product
Table 25. Danaher Corporation High Throughput Screening (HTS) Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Danaher Corporation Recent Developments
Table 27. Thermofisher Scientific, Inc. Company Details
Table 28. Thermofisher Scientific, Inc. Business Overview
Table 29. Thermofisher Scientific, Inc. High Throughput Screening (HTS) Product
Table 30. Thermofisher Scientific, Inc. High Throughput Screening (HTS) Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Thermofisher Scientific, Inc. Recent Developments
Table 32. PerkinElmer, Inc. Company Details
Table 33. PerkinElmer, Inc. Business Overview
Table 34. PerkinElmer, Inc. High Throughput Screening (HTS) Product
Table 35. PerkinElmer, Inc. High Throughput Screening (HTS) Revenue in China Market (2016-2021) & (US$ Million)
Table 36. PerkinElmer, Inc. Recent Developments
Table 37. Tecan Group Ltd. Company Details
Table 38. Tecan Group Ltd. Business Overview
Table 39. Tecan Group Ltd. High Throughput Screening (HTS) Product
Table 40. Tecan Group Ltd. High Throughput Screening (HTS) Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Tecan Group Ltd. Recent Developments
Table 42. Merck Millipore Company Details
Table 43. Merck Millipore Business Overview
Table 44. Merck Millipore High Throughput Screening (HTS) Product
Table 45. Merck Millipore High Throughput Screening (HTS) Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Merck Millipore Recent Developments
Table 47. Bio-Rad Laboratories Company Details
Table 48. Bio-Rad Laboratories Business Overview
Table 49. Bio-Rad Laboratories High Throughput Screening (HTS) Product
Table 50. Bio-Rad Laboratories High Throughput Screening (HTS) Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Bio-Rad Laboratories Recent Developments
Table 52. Hamilton Company Company Details
Table 53. Hamilton Company Business Overview
Table 54. Hamilton Company High Throughput Screening (HTS) Product
Table 55. Hamilton Company High Throughput Screening (HTS) Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Hamilton Company Recent Developments
Table 57. Axxam S.p.A. Company Details
Table 58. Axxam S.p.A. Business Overview
Table 59. Axxam S.p.A. High Throughput Screening (HTS) Product
Table 60. Axxam S.p.A. High Throughput Screening (HTS) Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Axxam S.p.A. Recent Developments
Table 62. Aurora Biomed Company Details
Table 63. Aurora Biomed Business Overview
Table 64. Aurora Biomed High Throughput Screening (HTS) Product
Table 65. Aurora Biomed High Throughput Screening (HTS) Revenue in China Market (2016-2021) & (US$ Million)
Table 66. Aurora Biomed Recent Developments
List of Figures
Figure 1. High Throughput Screening (HTS) Segment by Type
Figure 2. High Throughput Screening (HTS) Segment by Application
Figure 3. China High Throughput Screening (HTS) Market Overview: 2020
Figure 4. China High Throughput Screening (HTS) Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China High Throughput Screening (HTS) Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by High Throughput Screening (HTS) Revenue in 2020
Figure 7. By Type - China High Throughput Screening (HTS) Revenue Market Share, 2016-2027
Figure 8. By Application - China High Throughput Screening (HTS) Revenue Market Share, 2016-2027
Figure 9. Agilent Technologies, Inc. High Throughput Screening (HTS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Danaher Corporation High Throughput Screening (HTS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Thermofisher Scientific, Inc. High Throughput Screening (HTS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. PerkinElmer, Inc. High Throughput Screening (HTS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Tecan Group Ltd. High Throughput Screening (HTS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Merck Millipore High Throughput Screening (HTS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Bio-Rad Laboratories High Throughput Screening (HTS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Hamilton Company High Throughput Screening (HTS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Axxam S.p.A. High Throughput Screening (HTS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Aurora Biomed High Throughput Screening (HTS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs